DPX-Survivac
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for DPX-Survivac, covering 2021-06-18 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer [Phase 1]